TIANDA PHARMA News

TIANDA PHARMA: (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUINGCONNECTED TRANSACTION WITH SPH;(II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH;AND(III) NOTICE OF EXTRAORDINARY GENERAL MEETING

Oct 18, 2023 16:31

TIANDA PHARMA: DELAY IN DESPATCH OF CIRCULAR

Oct 12, 2023 18:23

TIANDA PHARMA: (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH SPH AND(II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH

Sep 20, 2023 17:51

TIANDA PHARMA: DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF NON-CONTROLLING INTEREST IN A SUBSIDIARY

Aug 1, 2023 17:35

TIANDA PHARMA: CONNECTED TRANSACTIONSUBSCRIPTION OF INTEREST IN A FUND

Apr 19, 2023 18:42

TIANDA PHARMA: REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS

Dec 29, 2022 18:06

TIANDA PHARMA: CONTINUING CONNECTED TRANSACTIONS 2022 ANNUAL CAP EXCEEDED

Jun 24, 2022 17:30

TIANDA PHARMA: RENEWAL OF CONTINUING CONNECTED TRANSACTIONS

Apr 1, 2022 16:40

TIANDA PHARMA: COMPLETION OF CONNECTED AND MAJOR TRANSACTION DISPOSAL OF 100% EQUITY INTEREST OF A WHOLLY-OWNED SUBSIDIARY

Mar 29, 2022 17:22

TIANDA PHARMA: CONTINUING CONNECTED TRANSACTIONS: RENEWAL OF FRAMEWORK AGREEMENT WITH SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.

Apr 9, 2021 18:30

TIANDA PHARMA: SUPPLEMENTAL INFORMATION RELATING TO A DISCLOSABLE TRANSACTION-TECHNOLOGY TRANSFER CONTRACT

Mar 12, 2021 17:55

TIANDA PHARMA: DISCLOSEABLE TRANSACTION: TECHNOLOGY TRANSFER CONTRACT

Mar 4, 2021 18:24

TIANDA PHARMA: TERMINATION OF MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR

Dec 16, 2020 19:54

TIANDA PHARMA: MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR

Nov 24, 2020 16:51

TIANDA PHARMA: DELAY IN DESPATCH OF CIRCULAR AND GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES

Oct 27, 2020 19:14

TIANDA PHARMA: MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR

Oct 5, 2020 22:44

TIANDA PHARMA: CONTINUING CONNECTED TRANSACTIONS: REVISION OF ANNUAL CAPS AND EXTENSION OF PURCHASING PACKAGE PRODUCTS AND DESIGNING SERVICES

Feb 28, 2020 17:39

TIANDA PHARMA: Discloseable Transaction In Relation To The Main Contract For The New R&D And Production Base

Jun 13, 2019 18:03

TIANDA PHARMA: (1) CONNECTED AND MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF 100% EQUITY INTEREST OF A WHOLLY-OWNED SUBSIDIARY; AND(2) NOTICE OF EXTRAORDINARY GENERAL MEETING

Apr 12, 2019 17:03

TIANDA PHARMA: Delay in Despatch of Circular

Mar 15, 2019 18:01